Newsfeeds - Spark Newswire

1 minute read

Athenex Announces UK MHRA Validation Of The Marketing Authorization Application For Oral Paclitaxel And Encequidar For Review

Today, 8:13 PM

Athenex, Inc., (NASDAQ:ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, announced today that

ATNX

1 minute read

Athenex To Present Subgroup Analysis Of Oral Paclitaxel-Encequidar Combo Data From Breast Cancer Trial

By Vandana Singh

Today, 8:13 PM

Athenex Inc's (NASDAQ: ATNX) abstract for subgroup analysis of its Phase 3 study of oral paclitaxel and encequidar (Oral Paclitaxel) for metastatic breast cancer has been accepted for poster presentation at the 2021 San Antonio Breast Cancer Symposium.

ATNX

1 minute read

Events
News

Athenex To Present Subgroup Analysis From Phase 3 Study Of Oral Paclitaxel Plus Encequidar In Metastatic Breast Cancer At SABCS 2021

By Benzinga Newsdesk

Today, 8:13 PM

Analysis of safety data demonstrated that patients with elevated liver tests were at increased risk of neutropenia related toxicities Post hoc analysis of this subgroup of patients with hepatic impairment was

ATNX

2 minute read

News

Athenex Announces Exclusive License Agreement With National Cancer Institute To Utilize T Cell Receptors Targeting Mutated p53, KRAS, And EGFR For The Development Of Autologous And Allogeneic Cell Therapies

By Benzinga Newsdesk

Today, 8:13 PM

Athenex (NASDAQ:ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced a licensing

ATNX

32 minute read

Earnings Scheduled For November 4, 2021

By Benzinga Insights

Today, 8:13 PM

Companies Reporting Before The Bell • DISH Network (NASDAQ:DISH) is likely to report quarterly earnings at $0.91 per share on revenue of $4.45 billion.

AAOI

1 minute read

Earnings

Earnings Preview For Athenex

By Benzinga Insights

Today, 8:13 PM

Athenex (NASDAQ:ATNX) is set to give its latest quarterly earnings report on Thursday, 2021-11-04. Here's what investors need to know before the announcement. Analysts estimate that Athenex will likely report an Earnings Per Share (EPS) of $-0.37

ATNX

2 minute read

3 Penny Stocks Insiders Are Buying

By Lisa Levin

Today, 8:13 PM

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

ATNX